Novel Scaled Average Bioequivalence Limits Based on GMR and Variability Considerations

Author： Karalis Vangelis   Symillides Mira   Macheras Panos  

Publisher： Springer Publishing Company

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.21, Iss.10, 2004-10, pp. : 1933-1942

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Scaled Bioequivalence Limits with Leveling-off Properties

By Kytariolos John   Karalis Vangelis   Macheras Panos   Symillides Mira  

Pharmaceutical Research, Vol. 23, Iss. 11, 2006-11 ,pp. : 2657-2664

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of Bioequivalence for Highly Variable Drugs with Scaled Average Bioequivalence

By Tothfalusi Laszlo  

Clinical Pharmacokinetics, Vol. 48, Iss. 11, 2009-11 ,pp. : 725-743

Adis International

Access to resources Recommend Favorite

A Parametric Confidence Interval for a Moment-Based Scaled Criterion for Individual Bioequivalence

By Kimanani Ebi K.   Potvin Diane  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 25, Iss. 5, 1997-10 ,pp. : 595-614

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacodynamic considerations in bioequivalence assessment: comparison of novel and existing metrics

By Karalis V.   Macheras P.  

European Journal of Pharmaceutical Sciences, Vol. 19, Iss. 1, 2003-05 ,pp. : 45-56

Elsevier

Access to resources Recommend Favorite

Novel methods to assess bioequivalence

By Karalis Vangelis   Symillides Mira   Macheras Panos  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 1, 2011-01 ,pp. : 79-88

Informa Healthcare

Access to resources Recommend Favorite